These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19281086)

  • 1. Pulmonary and systemic hepatocyte and keratinocyte growth factors in patients with chronic obstructive pulmonary disease.
    Sauleda J; Noguera A; Blanquer D; Pons J; López M; Villena C; Agustí AG
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):719-25. PubMed ID: 19281086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease.
    Gasiuniene E; Lavinskiene S; Sakalauskas R; Sitkauskiene B
    COPD; 2016 Oct; 13(5):569-75. PubMed ID: 27018873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratinocyte growth factor and hepatocyte growth factor in bronchoalveolar lavage fluid in acute respiratory distress syndrome patients.
    Stern JB; Fierobe L; Paugam C; Rolland C; Dehoux M; Petiet A; Dombret MC; Mantz J; Aubier M; Crestani B
    Crit Care Med; 2000 Jul; 28(7):2326-33. PubMed ID: 10921560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Biologic and clinical significance.
    Verghese GM; McCormick-Shannon K; Mason RJ; Matthay MA
    Am J Respir Crit Care Med; 1998 Aug; 158(2):386-94. PubMed ID: 9700111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of placenta growth factor in COPD.
    Cheng SL; Wang HC; Yu CJ; Yang PC
    Thorax; 2008 Jun; 63(6):500-6. PubMed ID: 18202163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease.
    Moré JM; Voelker DR; Silveira LJ; Edwards MG; Chan ED; Bowler RP
    BMC Pulm Med; 2010 Oct; 10():53. PubMed ID: 20973980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous assessment of hepatocyte growth factor and vascular endothelial growth factor in epithelial lining fluid from patients with COPD.
    Kanazawa H; Tochino Y; Asai K; Hirata K
    Chest; 2014 Nov; 146(5):1159-1165. PubMed ID: 24832895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of hepatocyte growth factor in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis.
    Yamanouchi H; Fujita J; Yoshinouchi T; Hojo S; Kamei T; Yamadori I; Ohtsuki Y; Ueda N; Takahara J
    Respir Med; 1998 Feb; 92(2):273-8. PubMed ID: 9616525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of hepatocyte growth factor in bronchoalveolar lavage fluid in chronic interstitial lung diseases.
    Przybylski G; Chorostowska-Wynimko J; Dyczek A; Wędrowska E; Jankowski M; Szpechciński A; Giżycka A; Golińska J; Kopiński P
    Pol Arch Med Wewn; 2015; 125(4):260-71. PubMed ID: 25697336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and significance of immunoglobulin free light chains in serum and lung tissues from patients with chronic obstructive pulmonary disease].
    Zhang M; Tao HC; Li YQ; Pei HS; Zhu SY; Chen B; Zhou RJ; Zhang MW
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):945-9. PubMed ID: 24503428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPD.
    Holz O; Waschki B; Roepcke S; Watz H; Lauer G; Faulenbach C; Hohlfeld JM
    BMC Pulm Med; 2014 Mar; 14():30. PubMed ID: 24581181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of keratinocyte growth factor and hepatocyte growth factor levels in rat lung lavage fluid to epithelial cell regeneration after bleomycin.
    Adamson IY; Bakowska J
    Am J Pathol; 1999 Sep; 155(3):949-54. PubMed ID: 10487852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema.
    Löfdahl JM; Cederlund K; Nathell L; Eklund A; Sköld CM
    Eur Respir J; 2005 Feb; 25(2):275-81. PubMed ID: 15684291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of high-mobility group box 1 in the blood and lungs is associated with the development of chronic obstructive pulmonary disease in smokers.
    Ko HK; Hsu WH; Hsieh CC; Lien TC; Lee TS; Kou YR
    Respirology; 2014 Feb; 19(2):253-261. PubMed ID: 24372740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.
    Zhang L; Cheng Z; Liu W; Wu K
    COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
    Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
    Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of T-cell subsets in BAL fluid of patients with mild to moderate COPD depends on current smoking status and not airway obstruction.
    Forsslund H; Mikko M; Karimi R; Grunewald J; Wheelock ÅM; Wahlström J; Sköld CM
    Chest; 2014 Apr; 145(4):711-722. PubMed ID: 24264182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
    Ferhani N; Letuve S; Kozhich A; Thibaudeau O; Grandsaigne M; Maret M; Dombret MC; Sims GP; Kolbeck R; Coyle AJ; Aubier M; Pretolani M
    Am J Respir Crit Care Med; 2010 May; 181(9):917-27. PubMed ID: 20133931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
    Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A
    COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and significance of hypoxia-inducible factor-1α in patients with chronic obstructive pulmonary disease and smokers with normal lung function].
    Tao H; Luo W; Pei H; Zhu S; Zhang M; Chen B; He J; Zhang M; Zhou R
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):852-5. PubMed ID: 25108440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.